Juan Bueno
Bioprospecting development and consulting, Bogota,
Colombia
Review Article
Antimicrobial Adjuvants Drug Discovery, the Challenge of Avoid the
Resistance and Recover the Susceptibility of Multidrug-Resistant Strains
Author(s): Juan Bueno
Juan Bueno
Currently, the emergence of multidrug resistant microorganisms as Acinetobacter baumannii and Mycobacterium tuberculosis as well as new drug resistant forms of Neisseria gonorrhoeae in conjunction with the evolving of resistance genes as the KPC (class A Klebsiella pneumoniae) and NDM-1 (New Delhi metallo-β-lactamase 1) carbapenemases are a public health threat that requires great efforts in prevention, treatment and diagnosis. For that reason, the InterAcademy Panel and InterAcademy Medical Panel statement (IAP-IAMP) included in their Global recommendations call for action to tackle antimicrobial resistance under the following item “Encourage industry innovation and public-private collaborative research and development programs for therapeutics, diagnostics, and vaccines”. In this way, the development of novel antimicrobial drugs is not only necessary, is a priority .. View More»
DOI:
10.4172/1948-5948.1000281